A Vaccine Candidate Protects Non-Human Primates From SARS-CoV-2 Infection

A Vaccine Candidate Protects Non-Human Primates From SARS-CoV-2 Infection

Source: 
Forbes
snippet: 

A pre-print in BioRxiv from a Beijing based biotechnology company company, Sinovac, describes protection of macaque monkeys from infection by SARS-CoV-2 by a vaccine candidate. The candidate is a “killed virus” vaccine prepared by inactivating live virus with beta-Propriolactone, a standard procedure used in inactivate other viruses for use as vaccines. Alum, used in many vaccines, was added to the killed virus preparation to elicit a stronger immune response. To my knowledge this is the first published report of protection of non-human primates by a COVID-19 vaccine candidate.